Mateusz M. Pluciński

Author

Centers for Disease Control and Prevention ORCID

Also Known As

Assefa, Ashenafi, Christopher V. Plowe, Jessica Hofstetter, M. M. Plucinski, Mateusz M Plucinski, Mateusz M Pluciński, Mateusz M. Plucinski, Mateusz M. Pluciński, Mateusz Plucinski, Mateusz Pluciński

134

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention U.S. President's Malaria Initiative Division of Parasitic Diseases and Malaria Center for Global Health Ministry of Health

About

Mateusz M. Pluciński is an author at Centers for Disease Control and Prevention specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.5K
2	Public Health	13	14	994
3	Engineering	1	1	45
4	Health Sciences	1	1	16
5	Natural Sciences	1	1	10

Mateusz M. Pluciński

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Public Health Responses to COVID-19 Outbreaks on Cruise Ships — Worldwide, February–March 2020 Leah F. Moriarty, Mateusz M. Pluciński, Barbara J. Marston, MMWR Morbidity and Mortality Weekly Report Virus EpidemiologyCovid-19 OutbreaksDisease OutbreakCovid-19 EpidemiologyFebruary–march 2020	2020	426
Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities Mateusz M. Pluciński, Timothée Guilavogui, Sidikiba Sidibé, The Lancet Infectious Diseases	2015	149
Persisting Viral Sequences Shape Microbial CRISPR-based Immunity Ariel D. Weinberger, Christine Sun, Mateusz M. Pluciński, PLoS Computational Biology Viral EvolutionCrispr LociCrispr SystemImmune Crispr LineagesGenetics	2012	148
Selection and Spread of Artemisinin-Resistant Alleles in Thailand Prior to the Global Artemisinin Resistance Containment Campaign Eldin Talundzic, Sheila Okoth, Kanungnit Congpuong, PLoS Pathogens GeneticsMalariaGenetic EpidemiologyArtemisinin ResistanceGenomics	2015	125
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant Renato Mendes Coutinho, Flávia Maria Darcie Marquitti, Leonardo Souto Ferreira, Communications Medicine	2021	118
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Malaria in Children in Zaire and Uíge Provinces, Angola Mateusz M. Pluciński, Eldin Talundzic, Lindsay Morton, Antimicrobial Agents and Chemotherapy Disease ResistanceSoutheast AsiaAntiparasitic AgentMedicineMalaria	2014	91
Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests Eric Rogier, Mateusz M. Pluciński, Naomi W. Lucchi, PLoS ONE MedicineProteomicsBioanalysisMalariaImmunology	2017	83
Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015 Mateusz M. Pluciński, Pedro Rafael Dimbu, Aleixo Panzo Macaia, Malaria Journal	2017	81
Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance Eldin Talundzic, Shashidhar Ravishankar, Julia Kelley, Antimicrobial Agents and Chemotherapy	2018	80
Poverty, Disease, and the Ecology of Complex Systems Calistus N. Ngonghala, Mateusz M. Pluciński, Megan Murray, PLoS Biology	2014	78

Page 1